Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - Piramal Pharma Limited (''PPL'') Launches new campaign for ''Polycrol" with Brand Ambassador Jisshu Sengupta07-05-2024
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - Piramal Pharma Limited (''PPL'') Launches new campaign for ''Polycrol" with Brand Ambassador Jisshu SenguptaPiramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference Call with Investor/Analysts under the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015.Piramal Pharma Ltd - 543635 - Board Meeting Intimation for Board Meeting Intimation As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 ,inter alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended 31st March 2024 and to consider recommending payment of dividend to the shareholders.Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations')
Disclosure under Regualtion 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amednded (''SEBI Listing Regulations'')Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations')
Disclsoure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (''SEBI Listing Regulations'')Piramal Pharma Ltd - 543635 - Compliance Certificate Pursuant To Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Compliance Certificate pursuant to Regulation 40(10) of the SEBI Listing Regulations.Piramal Pharma Ltd - 543635 - Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') For The Financial Year Ended 31St March, 2024
Compliance Certificate pursuant to Regulation 7(3) of the Listing Regulations for financial year ended 31st March, 2024.Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Successful Closure Of US FDA Inspection At Piramal Pharma'S Manufacturing Facility Located At Riverview, USA
Successful closure of US FDA Inspection at Piramal Pharma''s manufacturing facility located at Riverview, USAPiramal Pharma forays into men's grooming with BOHEM
This includes a hair removal spray, a beard growth oil, and an underarm roll-on, the company said, adding that BOHEM drew from Bohemian' signifying unconventional identity or lifestylePiramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release- Piramal Pharma Limited (''the Company'') forays into men''s grooming market with the launch of BOHEM.